Cargando…
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line
Myxofibrosarcoma (MFS) belongs to the group of sarcoma tumors, which represent only 1% of the totality of adult tumors worldwide. Thus, given the rare nature of this cancer, this makes the availability of MFS cell lines difficult. In an attempt to partially fill this gap, we immortalized a primary c...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262427/ https://www.ncbi.nlm.nih.gov/pubmed/30366467 http://dx.doi.org/10.3390/cells7110186 |
_version_ | 1783375103663276032 |
---|---|
author | Miserocchi, Giacomo De Vita, Alessandro Mercatali, Laura Recine, Federica Liverani, Chiara Spadazzi, Chiara Pieri, Federica Riva, Nada Bongiovanni, Alberto Casadei, Roberto Fausti, Valentina Ibrahim, Toni |
author_facet | Miserocchi, Giacomo De Vita, Alessandro Mercatali, Laura Recine, Federica Liverani, Chiara Spadazzi, Chiara Pieri, Federica Riva, Nada Bongiovanni, Alberto Casadei, Roberto Fausti, Valentina Ibrahim, Toni |
author_sort | Miserocchi, Giacomo |
collection | PubMed |
description | Myxofibrosarcoma (MFS) belongs to the group of sarcoma tumors, which represent only 1% of the totality of adult tumors worldwide. Thus, given the rare nature of this cancer, this makes the availability of MFS cell lines difficult. In an attempt to partially fill this gap, we immortalized a primary culture of MFS (IM-MFS-1) and compared the cell morphology with patient’s tumor tissue. IM-MFS-1 was genetically characterized through a Comparative Genomic Hybridization (CGH) array and the mesenchymal phenotype was evaluated using Polymerase chain reaction (PCR) and immunofluorescence staining. Drug sensitivity for MFS therapies was monitored over time in cultures. We confirmed the conservation of the patient’s tumor cell morphology and of the mesenchymal phenotype. Conversely, the synthesis and expression of CD109, a TGFβ co-receptor used to facilitate the diagnosis of high-grade MFS diagnosis, was maintained constant until high cancer cell line passages. The CGH array revealed a complex karyotype with cytogenetic alterations that include chromosome regions associated with genes involved in tumor processes. Cytotoxicity assays show drug sensitivity constantly increased during the culture passages until a plateau was reached. In conclusion, we established and characterized a new MFS cell line that can be used for future preclinical and molecular studies on soft tissue sarcomas. |
format | Online Article Text |
id | pubmed-6262427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62624272018-12-03 Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line Miserocchi, Giacomo De Vita, Alessandro Mercatali, Laura Recine, Federica Liverani, Chiara Spadazzi, Chiara Pieri, Federica Riva, Nada Bongiovanni, Alberto Casadei, Roberto Fausti, Valentina Ibrahim, Toni Cells Article Myxofibrosarcoma (MFS) belongs to the group of sarcoma tumors, which represent only 1% of the totality of adult tumors worldwide. Thus, given the rare nature of this cancer, this makes the availability of MFS cell lines difficult. In an attempt to partially fill this gap, we immortalized a primary culture of MFS (IM-MFS-1) and compared the cell morphology with patient’s tumor tissue. IM-MFS-1 was genetically characterized through a Comparative Genomic Hybridization (CGH) array and the mesenchymal phenotype was evaluated using Polymerase chain reaction (PCR) and immunofluorescence staining. Drug sensitivity for MFS therapies was monitored over time in cultures. We confirmed the conservation of the patient’s tumor cell morphology and of the mesenchymal phenotype. Conversely, the synthesis and expression of CD109, a TGFβ co-receptor used to facilitate the diagnosis of high-grade MFS diagnosis, was maintained constant until high cancer cell line passages. The CGH array revealed a complex karyotype with cytogenetic alterations that include chromosome regions associated with genes involved in tumor processes. Cytotoxicity assays show drug sensitivity constantly increased during the culture passages until a plateau was reached. In conclusion, we established and characterized a new MFS cell line that can be used for future preclinical and molecular studies on soft tissue sarcomas. MDPI 2018-10-25 /pmc/articles/PMC6262427/ /pubmed/30366467 http://dx.doi.org/10.3390/cells7110186 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miserocchi, Giacomo De Vita, Alessandro Mercatali, Laura Recine, Federica Liverani, Chiara Spadazzi, Chiara Pieri, Federica Riva, Nada Bongiovanni, Alberto Casadei, Roberto Fausti, Valentina Ibrahim, Toni Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title_full | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title_fullStr | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title_full_unstemmed | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title_short | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
title_sort | characterization and drug sensitivity of a new high-grade myxofibrosarcoma cell line |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262427/ https://www.ncbi.nlm.nih.gov/pubmed/30366467 http://dx.doi.org/10.3390/cells7110186 |
work_keys_str_mv | AT miserocchigiacomo characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT devitaalessandro characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT mercatalilaura characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT recinefederica characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT liveranichiara characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT spadazzichiara characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT pierifederica characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT rivanada characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT bongiovannialberto characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT casadeiroberto characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT faustivalentina characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline AT ibrahimtoni characterizationanddrugsensitivityofanewhighgrademyxofibrosarcomacellline |